This slide presentation summarizes the case of a 50-year-old man with fatigue and weight loss who was found to have lymphocytosis, anemia, hepatosplenomegaly, and lymphadenopathy. Peripheral blood smear, bone marrow biopsy, flow cytometry and cytogenetic testing supported a diagnosis of chronic lymphocytic leukemia (CLL) stage III. He was started on chemoimmunotherapy but did not improve, so he was considered for bone marrow transplantation. The presentation provides details on the epidemiology, clinical features, diagnostic criteria, prognostic factors, treatment approaches and histological transformation of CLL.
Dr. Feroze Momin presents Chronic Lymphocytic Leukemia - Review and new Insights.
To read about Dr. Feroze Momin: http://conquercancers.com/ourdoctorso1.html
To read about Cancer Treatment Center in Michigan:
http://conquercancers.com
The mononuclear phagocytic system consists of dendritic cells and monocyte/macrophages, historically referred to as histiocytes.
Rare and diverse conditions that affect both children and adults.
Range from benign skin lesions to rapidly life-threatening systemic disorders.
The best known histiocytoses, Langerhans cell histiocytosis (LCH), and hemophagocytic lymphohistiocytosis (HLH).
This document discusses pediatric AML, including subtypes seen in Down syndrome and infant leukemias. Pediatric AML is less common than in adults and presents variably with organomegaly, skin lesions, or respiratory distress. Risk factors include genetic syndromes and twins. The most common subtypes in children are M5 and M7. Treatment involves induction, consolidation, and stem cell transplant. Infant leukemias commonly have MLL rearrangements and a poor prognosis. Molecular testing helps classify these subtypes.
This presentation provides information about chronic myeloid leukemia (CML). It begins by outlining 8 learning objectives about CML, including defining it, describing its subtypes and epidemiology, explaining its pathophysiology and genetic alterations, comparing its clinical signs in different phases, and more. It then covers CML's introduction, pathogenesis involving the Philadelphia chromosome and BCR-ABL fusion gene, epidemiology and risk factors, clinical features in chronic and advanced phases, diagnosis methods including cytogenetics, and reference books for further information. The goal is for students to understand CML and be able to answer questions about classifying, detecting, diagnosing, and comparing its various aspects.
This document discusses acute leukemia, including definitions of blast cells, leukemia, and the differences between lymphoid and myeloid cells. It covers the pathophysiology of acute leukemia, techniques for diagnosis, classifications of acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML), treatment approaches, and prognosis. Key points include that ALL is most common in children while AML is more common in adults, cytogenetics help determine prognosis and treatment for both, and the cure rate for ALL can be as high as 90% in children but only 30% in adults.
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of mature-appearing B lymphocytes in the blood, bone marrow, lymph nodes, and spleen. It is considered a clonal B cell malignancy caused by a defect in apoptosis that allows long-lived, non-cycling lymphocytes to accumulate over time. CLL cells typically express CD5, CD19, and CD23 and have mutations that dysregulate pathways controlling cell survival and apoptosis. Prognosis depends on clinical features and genetic abnormalities - deletion of 13q or mutated IgVH correlate with better prognosis while deletion of 11q or 17p indicate poorer prognosis. CLL can transform into an aggressive lymphoma called Richter's syndrome over time.
This slide presentation summarizes the case of a 50-year-old man with fatigue and weight loss who was found to have lymphocytosis, anemia, hepatosplenomegaly, and lymphadenopathy. Peripheral blood smear, bone marrow biopsy, flow cytometry and cytogenetic testing supported a diagnosis of chronic lymphocytic leukemia (CLL) stage III. He was started on chemoimmunotherapy but did not improve, so he was considered for bone marrow transplantation. The presentation provides details on the epidemiology, clinical features, diagnostic criteria, prognostic factors, treatment approaches and histological transformation of CLL.
Dr. Feroze Momin presents Chronic Lymphocytic Leukemia - Review and new Insights.
To read about Dr. Feroze Momin: http://conquercancers.com/ourdoctorso1.html
To read about Cancer Treatment Center in Michigan:
http://conquercancers.com
The mononuclear phagocytic system consists of dendritic cells and monocyte/macrophages, historically referred to as histiocytes.
Rare and diverse conditions that affect both children and adults.
Range from benign skin lesions to rapidly life-threatening systemic disorders.
The best known histiocytoses, Langerhans cell histiocytosis (LCH), and hemophagocytic lymphohistiocytosis (HLH).
This document discusses pediatric AML, including subtypes seen in Down syndrome and infant leukemias. Pediatric AML is less common than in adults and presents variably with organomegaly, skin lesions, or respiratory distress. Risk factors include genetic syndromes and twins. The most common subtypes in children are M5 and M7. Treatment involves induction, consolidation, and stem cell transplant. Infant leukemias commonly have MLL rearrangements and a poor prognosis. Molecular testing helps classify these subtypes.
This presentation provides information about chronic myeloid leukemia (CML). It begins by outlining 8 learning objectives about CML, including defining it, describing its subtypes and epidemiology, explaining its pathophysiology and genetic alterations, comparing its clinical signs in different phases, and more. It then covers CML's introduction, pathogenesis involving the Philadelphia chromosome and BCR-ABL fusion gene, epidemiology and risk factors, clinical features in chronic and advanced phases, diagnosis methods including cytogenetics, and reference books for further information. The goal is for students to understand CML and be able to answer questions about classifying, detecting, diagnosing, and comparing its various aspects.
This document discusses acute leukemia, including definitions of blast cells, leukemia, and the differences between lymphoid and myeloid cells. It covers the pathophysiology of acute leukemia, techniques for diagnosis, classifications of acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML), treatment approaches, and prognosis. Key points include that ALL is most common in children while AML is more common in adults, cytogenetics help determine prognosis and treatment for both, and the cure rate for ALL can be as high as 90% in children but only 30% in adults.
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of mature-appearing B lymphocytes in the blood, bone marrow, lymph nodes, and spleen. It is considered a clonal B cell malignancy caused by a defect in apoptosis that allows long-lived, non-cycling lymphocytes to accumulate over time. CLL cells typically express CD5, CD19, and CD23 and have mutations that dysregulate pathways controlling cell survival and apoptosis. Prognosis depends on clinical features and genetic abnormalities - deletion of 13q or mutated IgVH correlate with better prognosis while deletion of 11q or 17p indicate poorer prognosis. CLL can transform into an aggressive lymphoma called Richter's syndrome over time.
The document discusses various aspects of customer satisfaction. It covers:
- The importance of treating customers as the top priority and understanding their needs beyond basic functions.
- Using customer satisfaction to measure quality and closely following customer demands.
- The relationship between customers, frontline employees, managers and the CEO in achieving satisfaction.
- Comparing what customers need versus what companies offer to ensure success.
- The importance of seeking ongoing customer feedback to understand changing expectations.
Steven Horwitz, M.D., Assistant Attending, Lymphoma Service, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center.
Presented at New Frontiers in the Management of Solid and Liquid Tumors hosted by the John Theurer Cancer Center at Hackensack University Medical Center. jtcancercenter.org/CME
The 60-year-old female presented with easy bruising, bleeding gums, and persistent nosebleeds. Laboratory tests showed a very low platelet count. A bone marrow biopsy showed increased megakaryocytes. These findings are consistent with a diagnosis of chronic idiopathic thrombocytopenic purpura (ITP). ITP is an autoimmune disorder where antibodies destroy platelets. Treatment options include corticosteroids, intravenous immunoglobulin, anti-D antibody, splenectomy, thrombopoietin receptor agonists, and platelet transfusions. The goal of treatment is to raise the platelet count and prevent bleeding complications.
The slides give brief information about brain tumor ,its types and symptoms.
The presentation will help you to know more about a condition leading to neurological disturbances.
This document defines Total Quality Management and outlines its key principles and tools. It discusses the need for TQM to develop world-class organizations, continuously reduce costs and improve quality. The pillars of TQM are identified as products, processes, systems, people and leadership. Quality improvement tools like histograms, Pareto charts, scatter diagrams and control charts are presented. The economic justification of TQM is that it leads to lower costs and higher profits for companies that implement it properly. The advantages of TQM include improved competitiveness, profitability, sales and market share.
Total Quality Management (TQM) is a management approach focused on customer satisfaction through continual improvement involving all employees. It uses strategies like process-centered thinking, fact-based decision making, and strategic planning to integrate quality into the organization's culture. The primary elements of TQM include having a customer focus, total employee involvement, a process-centered view, an integrated system, and a strategic and systematic approach to continual improvement. Organizations can implement TQM using approaches like focusing on key elements, following quality gurus, modeling successful organizations, adopting Japanese quality methods, or using quality award criteria.
Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal stem cell disorders where the bone marrow cannot produce blood cells effectively. Patients present with varying degrees of cytopenias. MDS may progress to acute leukemia. The WHO classification system recognizes subtypes based on blast percentage and cytogenetics that provide prognostic information. MDS results from genetic mutations and epigenetic changes in hematopoietic stem cells. Presenting signs include anemia, infections, and bleeding due to cytopenias. Evaluation involves blood tests, bone marrow aspiration/biopsy, and cytogenetics. Refractory cytopenia with unilineage dysplasia is the most common subtype.
This document discusses leukemias and provides information about leukemoid reactions. It defines a leukemoid reaction as a high white blood cell count with neutrophilia usually in response to infection, which can mimic chronic myelogenous leukemia or acute myeloid leukemia. The document notes that serum leukocyte alkaline phosphatase is normally elevated in leukemoid reactions, distinguishing it from CML where it is depressed. Features suggesting a leukemoid reaction rather than leukemia include toxic granulation, a high LAP score, and an obvious cause of the neutrophilia such as infection. The document provides several potential causes of leukemoid reactions and discusses methods for distinguishing leukemoid reactions from leukemia.
What is Acute Lymphoblastic Leukemia?
Acute Lymphoblastic leukemia (ALL), is a cancer that starts from white blood cells called lymphocytes in the bone marrow (the soft inner part of the bones, where new blood cells are generated).
http://www.bmthospitalindia.com/Adult-Acute-Lymphoblastic-Leukemia.html
The document provides guidelines for the diagnosis, treatment indications, response assessment, and supportive management of chronic lymphocytic leukemia (CLL). It summarizes updates to the understanding of genomic alterations in CLL like TP53 mutations and their prognostic role. It also discusses clinical staging, assessment of organomegaly and lymphadenopathy, response criteria for novel drugs, and monitoring of minimal residual disease. Diagnosis of CLL requires verification through blood smear, immunophenotyping and genetics. Prognostic markers like immunoglobulin variable gene mutational status, cytogenetics, serum markers, and immunophenotype are also covered.
Multiple myeloma is a malignant proliferation of plasma cells in the bone marrow that produces monoclonal immunoglobulins. It causes organ dysfunction through tumor infiltration, paraprotein production, and impaired immunity. Common signs include bone pain, fractures, infections, anemia, renal failure, and hypercalcemia. Diagnosis is based on bone marrow plasmacytosis, monoclonal proteins, and organ or tissue impairment. Treatment aims to relieve symptoms, control disease activity, extend survival, and preserve quality of life. Novel agents like bortezomib provide additional options for patients with relapsed or refractory disease.
Total Quality Management is a management approach centered on quality that aims to achieve long-term success through customer satisfaction. It involves applying various elements with synergy, including:
1. Top management leadership and constancy of purpose with a long-term commitment to quality.
2. A focus on processes and continuous improvement.
3. Total employee involvement and teamwork.
4. Training and developing a quality culture.
5. Using quantitative methods and data-driven decision making.
This document provides information on chronic lymphocytic leukemia (CLL), including its definition, diagnosis, incidence, aetiology, clinical features, diagnostic tests, staging systems, prognostic factors, and treatment approaches.
Some key points include:
- CLL is defined as the progressive accumulation of long-lived, functionally incompetent B lymphocytes.
- Diagnosis involves evaluating lymphocyte counts, immunophenotyping, bone marrow biopsy, and cytogenetic/molecular testing.
- Incidence is highest in Western adults over age 65 and is more common in men.
- Prognostic factors include genetic abnormalities, IgV gene mutation status, and response to initial therapy.
- Treatment depends on
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults. It has an average incidence of 2.7 per 100,000 people in the US and is more common in older men. CLL accounts for about 0.8% of all cancers and 30% of leukemias. The neoplastic cells are typically B-cell lymphocytes. Farming exposure and hepatitis C may play a role in etiology. CLL has various genetic abnormalities that affect prognosis. Clinical features include lymphadenopathy, fatigue, infections. Diagnosis requires a sustained lymphocytosis above 5000/uL. Treatment is indicated for symptomatic disease, doubling time under 6 months, or disease complications. Prognostic factors
This document discusses leukemia, specifically focusing on acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). It defines leukemia as cancer that starts in blood forming cells of the bone marrow. ALL and AML are described as the two most common types of childhood leukemia. Treatment for ALL typically involves induction, consolidation, and maintenance phases over 2.5 years using chemotherapy. AML treatment often begins with a "7+3" induction regimen combining cytarabine and an anthracycline. Prognosis is generally worse for adults and related to age for both ALL and AML.
1. Acute myelogenous leukemia (AML) is a clonal, malignant disease characterized by accumulation of abnormal blast cells in the bone marrow and impaired production of normal blood cells.
2. AML results from a series of somatic mutations in a primitive hematopoietic progenitor cell. Additional mutations are required for progression to AML.
3. Standard induction treatment involves "7+3" chemotherapy with cytarabine and an anthracycline, achieving remission in 55-90% of patients. Post-remission therapy aims to prolong remission.
The document discusses various aspects of customer satisfaction. It covers:
- The importance of treating customers as the top priority and understanding their needs beyond basic functions.
- Using customer satisfaction to measure quality and closely following customer demands.
- The relationship between customers, frontline employees, managers and the CEO in achieving satisfaction.
- Comparing what customers need versus what companies offer to ensure success.
- The importance of seeking ongoing customer feedback to understand changing expectations.
Steven Horwitz, M.D., Assistant Attending, Lymphoma Service, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center.
Presented at New Frontiers in the Management of Solid and Liquid Tumors hosted by the John Theurer Cancer Center at Hackensack University Medical Center. jtcancercenter.org/CME
The 60-year-old female presented with easy bruising, bleeding gums, and persistent nosebleeds. Laboratory tests showed a very low platelet count. A bone marrow biopsy showed increased megakaryocytes. These findings are consistent with a diagnosis of chronic idiopathic thrombocytopenic purpura (ITP). ITP is an autoimmune disorder where antibodies destroy platelets. Treatment options include corticosteroids, intravenous immunoglobulin, anti-D antibody, splenectomy, thrombopoietin receptor agonists, and platelet transfusions. The goal of treatment is to raise the platelet count and prevent bleeding complications.
The slides give brief information about brain tumor ,its types and symptoms.
The presentation will help you to know more about a condition leading to neurological disturbances.
This document defines Total Quality Management and outlines its key principles and tools. It discusses the need for TQM to develop world-class organizations, continuously reduce costs and improve quality. The pillars of TQM are identified as products, processes, systems, people and leadership. Quality improvement tools like histograms, Pareto charts, scatter diagrams and control charts are presented. The economic justification of TQM is that it leads to lower costs and higher profits for companies that implement it properly. The advantages of TQM include improved competitiveness, profitability, sales and market share.
Total Quality Management (TQM) is a management approach focused on customer satisfaction through continual improvement involving all employees. It uses strategies like process-centered thinking, fact-based decision making, and strategic planning to integrate quality into the organization's culture. The primary elements of TQM include having a customer focus, total employee involvement, a process-centered view, an integrated system, and a strategic and systematic approach to continual improvement. Organizations can implement TQM using approaches like focusing on key elements, following quality gurus, modeling successful organizations, adopting Japanese quality methods, or using quality award criteria.
Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal stem cell disorders where the bone marrow cannot produce blood cells effectively. Patients present with varying degrees of cytopenias. MDS may progress to acute leukemia. The WHO classification system recognizes subtypes based on blast percentage and cytogenetics that provide prognostic information. MDS results from genetic mutations and epigenetic changes in hematopoietic stem cells. Presenting signs include anemia, infections, and bleeding due to cytopenias. Evaluation involves blood tests, bone marrow aspiration/biopsy, and cytogenetics. Refractory cytopenia with unilineage dysplasia is the most common subtype.
This document discusses leukemias and provides information about leukemoid reactions. It defines a leukemoid reaction as a high white blood cell count with neutrophilia usually in response to infection, which can mimic chronic myelogenous leukemia or acute myeloid leukemia. The document notes that serum leukocyte alkaline phosphatase is normally elevated in leukemoid reactions, distinguishing it from CML where it is depressed. Features suggesting a leukemoid reaction rather than leukemia include toxic granulation, a high LAP score, and an obvious cause of the neutrophilia such as infection. The document provides several potential causes of leukemoid reactions and discusses methods for distinguishing leukemoid reactions from leukemia.
What is Acute Lymphoblastic Leukemia?
Acute Lymphoblastic leukemia (ALL), is a cancer that starts from white blood cells called lymphocytes in the bone marrow (the soft inner part of the bones, where new blood cells are generated).
http://www.bmthospitalindia.com/Adult-Acute-Lymphoblastic-Leukemia.html
The document provides guidelines for the diagnosis, treatment indications, response assessment, and supportive management of chronic lymphocytic leukemia (CLL). It summarizes updates to the understanding of genomic alterations in CLL like TP53 mutations and their prognostic role. It also discusses clinical staging, assessment of organomegaly and lymphadenopathy, response criteria for novel drugs, and monitoring of minimal residual disease. Diagnosis of CLL requires verification through blood smear, immunophenotyping and genetics. Prognostic markers like immunoglobulin variable gene mutational status, cytogenetics, serum markers, and immunophenotype are also covered.
Multiple myeloma is a malignant proliferation of plasma cells in the bone marrow that produces monoclonal immunoglobulins. It causes organ dysfunction through tumor infiltration, paraprotein production, and impaired immunity. Common signs include bone pain, fractures, infections, anemia, renal failure, and hypercalcemia. Diagnosis is based on bone marrow plasmacytosis, monoclonal proteins, and organ or tissue impairment. Treatment aims to relieve symptoms, control disease activity, extend survival, and preserve quality of life. Novel agents like bortezomib provide additional options for patients with relapsed or refractory disease.
Total Quality Management is a management approach centered on quality that aims to achieve long-term success through customer satisfaction. It involves applying various elements with synergy, including:
1. Top management leadership and constancy of purpose with a long-term commitment to quality.
2. A focus on processes and continuous improvement.
3. Total employee involvement and teamwork.
4. Training and developing a quality culture.
5. Using quantitative methods and data-driven decision making.
This document provides information on chronic lymphocytic leukemia (CLL), including its definition, diagnosis, incidence, aetiology, clinical features, diagnostic tests, staging systems, prognostic factors, and treatment approaches.
Some key points include:
- CLL is defined as the progressive accumulation of long-lived, functionally incompetent B lymphocytes.
- Diagnosis involves evaluating lymphocyte counts, immunophenotyping, bone marrow biopsy, and cytogenetic/molecular testing.
- Incidence is highest in Western adults over age 65 and is more common in men.
- Prognostic factors include genetic abnormalities, IgV gene mutation status, and response to initial therapy.
- Treatment depends on
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults. It has an average incidence of 2.7 per 100,000 people in the US and is more common in older men. CLL accounts for about 0.8% of all cancers and 30% of leukemias. The neoplastic cells are typically B-cell lymphocytes. Farming exposure and hepatitis C may play a role in etiology. CLL has various genetic abnormalities that affect prognosis. Clinical features include lymphadenopathy, fatigue, infections. Diagnosis requires a sustained lymphocytosis above 5000/uL. Treatment is indicated for symptomatic disease, doubling time under 6 months, or disease complications. Prognostic factors
This document discusses leukemia, specifically focusing on acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). It defines leukemia as cancer that starts in blood forming cells of the bone marrow. ALL and AML are described as the two most common types of childhood leukemia. Treatment for ALL typically involves induction, consolidation, and maintenance phases over 2.5 years using chemotherapy. AML treatment often begins with a "7+3" induction regimen combining cytarabine and an anthracycline. Prognosis is generally worse for adults and related to age for both ALL and AML.
1. Acute myelogenous leukemia (AML) is a clonal, malignant disease characterized by accumulation of abnormal blast cells in the bone marrow and impaired production of normal blood cells.
2. AML results from a series of somatic mutations in a primitive hematopoietic progenitor cell. Additional mutations are required for progression to AML.
3. Standard induction treatment involves "7+3" chemotherapy with cytarabine and an anthracycline, achieving remission in 55-90% of patients. Post-remission therapy aims to prolong remission.
Alpha Academy is an online platform that aims to help people maximize their potential and achieve success. It provides free knowledge resources as well as paid individualized advising and training programs. The document promotes becoming an Alpha Advisor, where individuals can offer their advice and expertise to others online and get compensated for it. Advisors have flexibility and opportunities to expand their influence through online seminars, publications, and more. The goal is to create a world where everyone can develop and apply their talents and strengths.
This document advertises an online academy called Alpha Academy that aims to maximize people's potential. It provides online individual advisory, know-how resources, and online "dojo" classes. Mentors can teach classes and provide individual advisory to students online and earn hourly wages or commissions. The academy recruits people to become Alpha mentors to support students and help them succeed in areas like exams, career changes, studying abroad, and hobbies.
This document provides information about preparing for the TOEFL exam. It discusses what the TOEFL exam measures, the section formats and time limits, and strategies for achieving high scores. It emphasizes that the answers to all questions are written in the passages and can be found through a process of elimination. Specific strategies are provided for the Reading section, such as skimming in 1.5 minutes to understand key points and structure before answering questions. The document stresses practicing official questions and tests to solidify the elimination technique of removing obviously wrong answers to arrive at the correct response.
This document provides information about English language proficiency tests such as IELTS and TOEFL, including:
- Conversion tables showing equivalent scores between IELTS, TOEFL, and TOEIC.
- Lists of top business schools that accept IELTS and GRE scores for admission.
- Details and recommendations for taking the IELTS exam, including strategies for the listening, reading, writing and speaking components. Scoring criteria and formats are explained for each section.
This document provides information about several topics related to the GRE:
- Lists top US and European business schools that accept the GRE for admissions. Includes each school's ranking.
- Describes the components of the GRE - Verbal, Quantitative, and Writing sections. Scoring is based on a 170 point scale for Verbal and Quantitative.
- Outlines a 3-day GRE training program covering Writing, Verbal, and Math sections. Provides sample questions and strategies for each section.
- Emphasizes the importance of vocabulary for the Verbal section and introduces a free vocabulary learning tool called "αVocab Dojo" for students.
This document is a presentation by Toshihiko Irisumi about his company, Alpha Academy, which provides advisory services for career coaching, studying abroad, and MBA/graduate school admissions. Some key points:
- Alpha Academy has helped over 150 students secure jobs at major trading companies in Japan and assisted many others with career changes.
- The company has achieved a 100% acceptance rate for MBA and graduate school applicants who received their advisory services, gaining admittance to top programs around the world.
- Alpha Academy offers GMAT preparation help and claims it can help students score a 700 or higher within 6 months to maximize their chances of MBA acceptance.
- Individual advisory services are available to
Alpha Academy is a study abroad advisory company that helps students get accepted to top universities and graduate schools around the world. It offers comprehensive advisory services, including resume and essay editing, test preparation, and interview coaching. The document highlights that Alpha Academy boasts a 100% acceptance rate for its students and can help applicants get into schools like Columbia, MIT, Cambridge and more. It promotes its individualized advising program and online resources to guide students through the entire application process.
1) Alpha Academy provides career advisory services to help clients succeed in obtaining jobs at top foreign consulting firms, investment banks, and trading companies through individualized coaching, video lectures, and an online community.
2) Their methods include helping clients thoroughly define career goals and target companies, create strong resumes and interview preparation, and obtain acceptance offers from places like McKinsey, BCG, Goldman Sachs, and trading firms.
3) Alpha Academy claims over 150 clients are accepted annually to trading companies, and they promise absolute acceptance rates for clients who fully commit to their training program of individual coaching, video lectures, and online community support.
1) Alpha Academy is an admissions consulting company that helps clients get accepted to top MBA and graduate school programs around the world.
2) They boast a 100% acceptance rate for clients who apply to programs with their assistance. Their services include video lectures, individual advising, essay/application reviews, and a community forum for clients.
3) In addition to application assistance, they provide test preparation support and guidance on resumes, interviews, program selection, and more to maximize clients' chances of admission success. Their goal is to ensure every client receives an acceptance letter.
This document provides information about Alpha Academy, an advisory firm that helps clients get accepted to top MBA programs. It discusses:
- Alpha Academy's mission to maximize potential and their network of graduates from top universities.
- An overview of what an MBA is, duration of programs, and rankings of top programs in the US, Europe, and globally.
- Detailed preparation needed for applications, including test scores, essays, recommendations, and interviews.
- Expenses of an MBA program and methods of paying for it.
- Career opportunities after an MBA like consulting, banking, and entrepreneurship.
- Alpha Academy's high acceptance rates at top schools and success placing students in jobs.
The document is an agenda from London Business School that provides an overview of the school. It discusses London Business School's reputation, outstanding peer group, world-class faculty, and location in London. It highlights the school's global reach with students from over 120 countries and over 40,000 alumni based in 150 countries. The document also summarizes London Business School's various degree programs, the career center's support, and admissions requirements and process.
This document provides an overview of the HEC Paris MBA program. It highlights that HEC Paris is an elite business school located in Paris that has been training business leaders since 1881. The two-year, full-time MBA program can also be completed part-time over 18-24 months and includes core courses, electives, international exchanges, and specialized tracks. Upon graduating, over 70% of students change job sectors or functions, with 90% being hired within three months and receiving an average salary package of 95k euros.
This document discusses preparing for an uncertain future career by gaining diverse international experience and developing collaborative skills through an MBA program like ESADE. It notes that the desired job may not exist in the future, may be too competitive to obtain, or one's interests may change during their studies. ESADE emphasizes developing flexibility, obtaining international experience through its diverse student body from over 70 countries, and enhancing teamwork skills through its collaborative learning approach.
Alpha Academy is an online academy that provides personalized support to help students achieve success in their careers and education. It offers lectures, personalized advising, and a community for competition and support. Members receive help getting accepted to top universities and graduate programs worldwide, earning high scores on exams, and obtaining jobs at top global companies. Services include video lectures, advising tailored to individual needs, and engaging with peers online. The goal is to maximize each member's potential and lead them to the success they aspire to achieve.
8. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
8
The Best U.S. MBA 2012 (BW)
1. University of Chicago (Booth)
2. Harvard University
3. University of Pennsylvania (Wharton)
4. Stanford University
5. Northwestern University (Kellogg)
6. Duke University (Fuqua)
7. Cornell University (Johnson)
8. University of Michigan, Ann Arbor (Ross)
9. Massachusetts Institute of Technology (Sloan)
10. University of Virginia (Darden)
11. Carnegie Mellon University (Tepper)
12. Dartmouth College (Tuck)
13. Columbia University
14. University of California, Berkeley (Haas)
15. Indiana University (Kelley)
9. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
9
欧米トップMBAの入学審査基準
n HBS：
① A Habit of Leadership
② Capacity for Intellectual Growth
③ Engaged Community Citizenship
n Stanford GSB:
① Intellectual Vitality
② Demonstrated Leadership Potential
③ Personal Qualities and Contributions
11. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
11
欧米トップMBAの入学審査基準
n GMAT : 680 over （620でKellogg合格！）
n TOEFL : 105 over （HBSは109以上）
n Essay:
• Convincing Essays (Clear Goal &
Professional/Social Activity)
n English Proficiency: Prove you can contribute to
the class and community
n Recommendation 2-3: Bosses, Clients, and
Professors
n Resume: Brilliant Experience
n GPA Transcript: Higher is the better
n Interview: Great character, deep understanding
of school, and realistic vision
15. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
欧米トップMBAが問う質問
・ コロンビア大学
Why are you pursuing an MBA at this point in your
career, and how do you plan to achieve your
immediate and long term post-MBA professional
goals?
・ スタンフォード大学
What matters most to you, and why?
What do you want to do̶REALLY̶
・ コロンビア大学、ペンシルバニア大学
Describe a personal experience and how it has
influenced who you are today. This essay should
have a personal rather than a professional focus.
23. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
欧米トップMBAが問う質問
・ コロンビア大学
Why are you pursuing an MBA at this point in your
career, and how do you plan to achieve your
immediate and long term post-MBA professional
goals?
・ スタンフォード大学
What matters most to you, and why?
What do you want to do̶REALLY̶
・ コロンビア大学、ペンシルバニア大学
Describe a personal experience and how it has
influenced who you are today. This essay should
have a personal rather than a professional focus.
60. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
欧米トップMBAが問う質問
・ コロンビア大学
Why are you pursuing an MBA at this point in your
career, and how do you plan to achieve your
immediate and long term post-MBA professional
goals?
・ スタンフォード大学
What matters most to you, and why?
What do you want to do̶REALLY̶
・ コロンビア大学、ペンシルバニア大学
Describe a personal experience and how it has
influenced who you are today. This essay should
have a personal rather than a professional focus.
89. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
IELTS受験可能ビジネススクール（2014 ＵＳ）
FT Rank in
2013
School name IELTS
1 Harvard Business School 7.5
2 Stanford Graduate School of Business 7
3 University of Pennsylvania: Wharton NG
5 Columbia Business School NG (TOEFL or PTE)
9 MIT: Sloan GMAT/GRE Verbal
10 University of Chicago: Booth 7
12 University of California at Berkeley: Haas 7
13 Northwestern University: Kellogg NG
14 Yale School of Management OK
16 Dartmouth College: Tuck OK
18 Duke University: Fuqua OK
19 New York University: Stern NG
23 UCLA: Anderson 7
24 Cornell University: Johnson OK
30 University of Michigan: Ross OK
90. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
IELTS受験可能ビジネススクール（2014 Europe）
FT Rank
in 2013
School name Country IELTS
4 London Business School UK OK
6 Insead
France /
Singapore
7.5
7 IESE Business School Spain 7.0
11 IE Business School Spain OK
16 University of Cambridge: Judge UK 7.5
19 IMD Switzerland NA
21 HEC Paris France OK
22 Esade Business School Spain 7.5
24 University of Oxford: Saïd UK 7.5
28 Warwick Business School UK 7.0
29 Manchester Business School UK 6.5
33 Rotterdam School of Management Netherlands OK
36
National University of Singapore
Business School
Singapore 6.5
92. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
GRE受験可能ビジネススクール（2014 ＵＳ）
FT Rank
in 2013
School name GRE
1 Harvard Business School OK
2 Stanford Graduate School of Business OK
3 University of Pennsylvania: Wharton OK
5 Columbia Business School OK
9 MIT: Sloan OK
10 University of Chicago: Booth OK
12 University of California at Berkeley: Haas OK
13 Northwestern University: Kellogg OK
14 Yale School of Management OK
16 Dartmouth College: Tuck OK
18 Duke University: Fuqua OK(GMAT preferred)
19 New York University: Stern OK
23 UCLA: Anderson OK
24 Cornell University: Johnson OK
30 University of Michigan: Ross OK
93. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
GRE受験可能ビジネススクール（2014 Non-US）
FT Rank
in 2012
School name Country GRE
4 London Business School UK OK
6 Insead
France /
Singapore
OK
7 IESE Business School Spain OK
11 IE Business School Spain OK
16 University of Cambridge: Judge UK OK
19 IMD Switzerland OK
21 HEC Paris France OK
22 Esade Business School Spain OK
24 University of Oxford: Saïd UK OK
29 Manchester Business School UK OK
33 Rotterdam School of Management Netherlands OK
36
National University of Singapore
Business School
Singapore OK
94. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
ご参考
• Cornell University: Q. GRE or GMAT? à … I still anticipate that a
large majority of applicants will submit with a GMAT score.
Although an increasing number of b-schools are now accepting
the GRE, the GMAT is still viewed as the common denominator
among applicants. With that said, this year we will be reviewing
a small percentage of applicants that have chosen to take the
GRE….
http://www.johnson.cornell.edu/Full-Time-MBA/Admissions/
Admissions-Blog/EntryId/139/GRE-or-GMAT-does-it-
matter.aspx
• London Business School: Q. Do you accept the GRE? à if you
have already taken the GRE, please contact our Admissions
Team with your tests information so we can discuss your
individual situation in more detail…….
http://www.london.edu/programmes/msc/faqs.html
94
97. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
対象者
97
• Candidates from bachelor degree programs
• Candidates from joint bachelor/graduate
degree programs
• Candidates from graduate degree programs
who have not held a full-time work position.
To be eligible for the 2+2 program,
candidates need to have gone directly from
undergraduate to graduate school.
To be considered for admission to the 2+2
Program Class of 2018 (entering Fall 2016), you
must be graduating from your program between
October 1, 2013 and September 30, 2014.
98. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
締切
98
• Summer Round: Application Deadline -
July 15, 2013
(Notification - September 4, 2013)
• Round 1: Application Deadline -
September 16, 2013
(Notification: December 11, 2013)
• Round 2: Application Deadline - January
6, 2014 (Notification: March 26, 2014)
• Round 3: Application Deadline - April 7,
2014 (Notification: May 14, 2014)
100. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
You re applying to Harvard Business School. We
can see your resume, school transcripts, extra-
curricular activities, awards, post-MBA career
goals, test scores and what your recommenders
have to say about you. What else would you like
us to know as we consider your candidacy? There
is no word limit for this question. We think you
know what guidance we're going to give here.
Don't overthink, overcraft and overwrite. Just
answer the question in clear language that those
of us who don't know your world can understand
100
HBS2+2 Essay
101. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
1. Selling points
2. Portfolio
• Leadership
• Intelligence
• Contributions
3. Stories: Tell who you are
4. Professional Format
101
RESUME
102. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
1. Please comment on the context of your interaction
with the applicant. If applicable, briefly describe
the applicant's role in your organization. (250
words)
2. How does the candidate's performance compare to
other well-qualified individuals in similar roles?
(250 words)
3. Please describe the most important piece of
constructive feedback you have given the applicant.
Please detail the circumstances and the applicant's
response. (250 words)
4. Please make additional statements about the
applicant's performance, potential, or personal
qualities you believe would be helpful to the MBA
Admissions Board. (250 words)
102
推薦状
104. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
2. GRE (Graduate Record Examination)
※2011年8月よりテストが改訂
Ø 定義 ： 大学院へ進学するのに必要な共通試験。一般知
識を問う General Test と、専門知識を問う Subject
Test があるが、科学系専攻を志望するもの以外の出願
には通常 General Test のスコアのみが必要である
Ø 構成： ①英語（Verbal Reasoning）、②数学
（Quantitative Reasoning）、③論文（Analytical
Writing）
Ø スコア： ①英語と②数学は130‐170の間でスコアが算
出される。③論文は0‐6でスコアが出る
Ø テスト時間： 約3‐4時間
Ø 有効期間： 5年間
104
Test - GRE
105. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
3. TOEFL (Test of English as a Foreign Language)
Ø 定義(Wikipedia) ： 外国語としての英語のテスト
Ø 構成： ①リーディング、②スピーキング、③リスニング、④
ライティング
Ø スコア： 各セクション30点満点、合計0‐120点で算出
Ø テスト時間： 約4時間
Ø 有効期限： 2年間
4. IELTS (International English Language Testing
System)
Ø 定義(Wikipedia) ： 英語熟練度を測る英語検定
Ø 構成： ①スピーキング、②リーディング、③リスニング、④
ライティング
Ø スコア： 各セクション及び合計スコアは1‐9で算出
Ø テスト時間： 2時間45分
Ø 有効期限： 2年間
105
Test – TOEFL & IELTS
106. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
n Admissions
Ø Total Applicants 828
Ø Admits 100
Ø % Admitted 12%
Ø Women 39% / International 20%
Ø Countries Represented 10
n Testing Information
Ø Complete Range of GMAT Scores 570-780
Ø Average GMAT 720
Ø Range of GRE Q 680-800 / Range of GRE V 570-800
Ø Average GRE Q 773 / Average GRE V 662
Ø Average GPA 3.76
n Educational Background
Ø Engineering/Natural Sciences/Technical Disciplines 60%
Ø Humanities & Social Sciences 34%
Ø Business Administration 6%
Ø Undergraduate Institutions Represented 45
106
Class Profile
107. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
1. HBS 2+2は通常のMBAアプリケーションプロセスで「アプ
ライしない」と予想される優秀層（法科大学院、公共政策大
学院、医学部等への進学希望者）を獲得する為のプロセス
2. 将来ビジネスフィールドに進むことが明確な学生は通常の
MBAアプリケーションプロセスで出願する可能性が高い
3. その他、女性や理系の学生を探しているとも言われている
4. 但し、アドミッション側は学生の経歴に関わらず、以下3つの
要素を満たしている学生を受け入れると言う
I. Strong leadership
II. Intellectual growth
III. Community engagement
107
HBS 2+2の「噂」
118. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
フルブライト・ケース（エッセイ）
• STUDY/RESEARCH OBJECTIVES and BIBLIOGRAPHY
Write a clear and detailed description of your study objectives, giving
your reasons for wanting to pursue them. Please include or attach a
bibliography. Be specific about your major field and your specialized
interests within this field. Describe the kind of program you expect to
undertake, and explain how your study plan fits in with your previous
training and your future objectives. This statement is an essential part
of your application.
PERSONAL STATEMENT
This personal statement should be a narrative statement describing
how you have achieved your current goals. It should not be a mere
listing of facts. It should include information about your education,
practical experience, special interests, and career plans. Describe any
significant factors that have influenced your educational or
professional development. Comment on the number of years of
practical experience already completed in the field in which academic
work will be done in the U.S. Do not mention specific U.S. universities at
which you would like to study.
なぜフルブライト奨学金を申請するのか、渡米中どのような活動を行いたいのか、将来設計
等含め、自由に自己アピールしてください。ちなみにこちらは夏の本締切のエッセイで、他
に推薦状三通が必要です。 118
124. (C) 2015 アルファ・アンド・カンパニー
Strictly Confidential
予備審査！
21. 予定専攻分野 / 23. TOPIC
24.★Project Area
1. 米国の研究 [AS]
2. 環太平洋地域の政治・経済関係 [PB]
3. 現代社会の諸問題 [CS]
4. グローバル社会の課題 [TI]
5. 教育 [ED]
ACADEMIC PROPOSAL IN U.S. 適宜改行を使って入力して下さい。
27.★研究テーマ （23.の和文抄訳を50字以内で入力。）
28.★Brief summary of project （Describe in 250-350 words in
English. 半角2200字以内、改行数15以内で入力。）
29.Background/Feasibility （If 21. is different from your current/
previous academic background, please explain the reason and the
feasibility of your plan in the U.S. Describe in 100-150 words in
English. 半角1200字以内、改行数5以内で入力。）
30.★Justification for the proposal （Please give specific reasons
why your proposal falls in that Project area, 24. Describe in
100-150 words in English. 半角1200字以内、改行数5以内で入力。）
